hepatitis C

Latest Headlines

Latest Headlines

Pricey hep C drugs force insurers into ethical dilemma

Since the introduction of two expensive drugs that treat hepatitis C last year, insurers have been forced to make some tough ethical decisions regarding which members can receive the medicines.

Specialty drug use high among exchange enrollees

New enrollees who purchased coverage through state and federal marketplaces are more likely to use specialty medications, such as those used to treat HIV/AIDs and hepatitis C, than people enrolled in commercial health plans, Express Scripts research finds.

Insurers want states to cover pricey hep C drugs

New hepatitis C treatments could cost at least $200 billion in the next five years, prompting insurers to ask state officials to help pick up the tab.